Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Sees Significant Decrease in Short Interest

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) was the recipient of a significant decline in short interest during the month of April. As of April 15th, there was short interest totalling 280,500 shares, a decline of 18.1% from the March 31st total of 342,600 shares. Currently, 0.9% of the shares of the stock are short sold. Based on an average daily volume of 63,900 shares, the days-to-cover ratio is currently 4.4 days.

Institutional Trading of Bioceres Crop Solutions

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Activest Wealth Management purchased a new position in Bioceres Crop Solutions in the 1st quarter valued at about $30,000. Cape Investment Advisory Inc. acquired a new position in shares of Bioceres Crop Solutions in the fourth quarter valued at approximately $33,000. One Degree Advisors Inc purchased a new position in shares of Bioceres Crop Solutions during the fourth quarter valued at approximately $291,000. Raymond James & Associates boosted its position in Bioceres Crop Solutions by 4.9% during the third quarter. Raymond James & Associates now owns 27,567 shares of the company’s stock worth $311,000 after acquiring an additional 1,300 shares during the last quarter. Finally, Federated Hermes Inc. boosted its position in Bioceres Crop Solutions by 8.5% during the third quarter. Federated Hermes Inc. now owns 141,684 shares of the company’s stock worth $1,600,000 after acquiring an additional 11,057 shares during the last quarter. Hedge funds and other institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Price Performance

Shares of NASDAQ BIOX traded down $0.03 on Friday, hitting $12.05. The company’s stock had a trading volume of 50,913 shares, compared to its average volume of 27,631. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.24 and a quick ratio of 0.84. The stock has a 50 day moving average of $12.72 and a 200-day moving average of $12.54. Bioceres Crop Solutions has a 12-month low of $9.76 and a 12-month high of $14.20. The company has a market capitalization of $756.74 million, a price-to-earnings ratio of 37.66 and a beta of 0.58.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its earnings results on Thursday, February 8th. The company reported $0.09 EPS for the quarter, beating analysts’ consensus estimates of $0.07 by $0.02. Bioceres Crop Solutions had a return on equity of 5.96% and a net margin of 4.36%. The firm had revenue of $140.30 million for the quarter, compared to analysts’ expectations of $108.97 million. During the same quarter in the prior year, the firm earned ($0.14) EPS. As a group, research analysts predict that Bioceres Crop Solutions will post 0.45 EPS for the current year.

Wall Street Analyst Weigh In

Separately, Roth Mkm upped their target price on Bioceres Crop Solutions from $20.00 to $21.00 and gave the company a “buy” rating in a report on Friday, February 9th.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.